Exploring how paternal age affects sperm selection in IVF
Official title: The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture
Run by Reproductive Medicine Associates of New Jersey · NCT06629766 · Data updated 2026-11-12
This study tests if using a new sperm selection device helps men of different ages have better success with IVF compared to the traditional method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 41 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Reproductive Medicine Associates of New Jersey Academic / other |
| Locations | 1 site (Basking Ridge, New Jersey) |
| Status | Recruiting |
| Started | April 9, 2025 |
| Main results expected | January 2027 |
| Study ends | December 2028 |
| Registry record updated | June 3, 2026 |
| Trial ID | NCT06629766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are couples undergoing their first IVF cycle with specific criteria regarding female age, ovarian reserve, and embryo quality.
✕Probably not a fit
Patients with male partners who have azoospermia, oligozoospermia, or other significant sperm quality issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of paternal age on sperm quality and reproductive success in patients undergoing in vitro fertilization (IVF). It compares the effectiveness of a microfluidic sperm selection device (Zymot) against the traditional density gradient centrifugation method for preparing sperm for intracytoplasmic sperm injection (ICSI). The study will assess various embryology parameters, including DNA fragmentation and clinical pregnancy outcomes, in a randomized control trial format. Participants will be monitored throughout their IVF cycle to evaluate the outcomes of using different sperm preparation techniques.
Why it matters
Potential benefit: If successful, this study could enhance IVF success rates by optimizing sperm selection methods based on paternal age.
How similar studies have gone: While there have been studies on sperm selection methods, this specific approach considering paternal age is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Undergoing first IVF cycle * Electing single embryo transfer * Electing PGT-A of their embryos * Female partners age \<42 years old at start of VOR cycle, but \>18 years old. * AMH ≥ 1.2 ng/mL * AFC ≥ 8 * FSH ≤ 12IU/L * At least 4 mature oocytes (M2s) retrieved at the VOR procedure in order to randomize * Intention to transfer the morphological best quality, euploid, embryo at the frozen embryo transfer procedure Exclusion Criteria: * Contraindication to IVF * Clinical indication for preimplantation genetic testing (i.e., screening for single gene disorder, chromosomal translocation, or any other disorders requiring a more detailed embryo genetic analysis) * Male partner with azoospermia or oligozoospermia (\<500,000 total motile spermatozoa on the most recent semen analysis within one year of enrollment) * Planned for previously cryopreserved sperm to be used for ICSI * Donor sperm * Male partner with Y-chromosome microdeletion * Male partner with any Karyotype other than 46,XY * Male partner requiring surgically obtained sperm either via testicular or epididymal retrieval procedures * Uncorrected hydrosalpinges that communicate with the endometrial cavity * Endometrial Insufficiency, as defined by a prior cycle with maximal endometrial thickness \<6mm,), or persistent endometrial fluid * Donor oocyte or embryo cycles * Gestational carriers
Where it's running
-
Reproductive Medicine Associates of New Jersey
Basking Ridge, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Kassie Bollig, MD, MSCE — Reproductive Medicine Associates of New Jersey
- Study coordinator: Caroline Clinical Research Nurse, BSN, RN
- Email: clinicalresearchteam@ivirma.com
- Phone: 973-656-2841
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differential Granulosa Cell Transcriptome Profiling to Predict Ongoing Pregnancy
Aiming to see if differences in granulosa cell gene activity can predict ongoing pregnancy in IVF and oocyte donation with PGT-A.
-
Detoxify for IVF: Cutting Everyday Pollutants to Help Infertility
This study tests a guide to help IVF patients reduce everyday environmental pollutants and sees if it lowers chemical exposure in urine, blood, and follicular fluid.
-
Carnitine and related supplements before IVF to see if they improve oocytes and embryos
This trial tests whether taking a supplement mix that includes L-carnitine before IVF helps improve the number and quality of eggs and embryos and the chances of pregnancy for women undergoing IVF.
-
Higher or lower starting FSH dose for good-prognosis IVF with PPOS
This trial tests whether starting IVF stimulation with 225 IU or 300 IU of FSH improves oocyte and embryo outcomes in good-prognosis women using PPOS.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.